Skip to main content

Epilepsy and Bone Health

  • Reference work entry
Book cover Atlas of Epilepsies
  • 223 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 599.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Babayigit A, Dirik E, Bober E, Cakmakci H (2006) Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 35:177–181

    Article  PubMed  Google Scholar 

  • Camfield P, Camfield C (1994) Acute and chronic toxicity of antiepileptic medications: a selective review. Can J Neurol Sci 21:S7–S11

    CAS  PubMed  Google Scholar 

  • Cansu A, Yesilkaya E, Serdaroglu A, Hirfanoglu TL, Camurdan O, Gulbahar O, Gucuyener K, Cinaz P (2008) Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 39:266–271

    Article  PubMed  Google Scholar 

  • Chou IJ, Lin KL, Wang HS, Wang CJ (2007) Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan 48:317–322

    PubMed  Google Scholar 

  • Chung S, Ahn C (1994) Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 16:382–385

    Article  CAS  PubMed  Google Scholar 

  • Cizza G, Ravn P, Chrousos GP, Gold PW (2001) Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 12:198–203

    Article  CAS  PubMed  Google Scholar 

  • Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767

    Article  PubMed  Google Scholar 

  • Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47

    Article  PubMed  Google Scholar 

  • Ecevit C, Aydogan A, Kavakli T, Altinoz S (2004) Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 31:279–282

    Article  PubMed  Google Scholar 

  • El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA (2008) Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 43:149–155

    Article  CAS  PubMed  Google Scholar 

  • Elliott JO, Lu B, Moore JL, McAuley JW, Long L (2008) Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005. Epilepsy Behav 13:307–315

    Article  PubMed  Google Scholar 

  • Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL (2004) Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62:2051–2057

    CAS  PubMed  Google Scholar 

  • Ensrud KE, Walczak TS, Blackwell TL, Ensrud ER, Barrett-Connor E, Orwoll ES (2008) Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 71:723–730

    Article  CAS  PubMed  Google Scholar 

  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:1348–1353

    CAS  PubMed  Google Scholar 

  • Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA (2000) Long-term anticonvulsant therapy leads to low bone mineral density – evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes 108:37–43

    CAS  PubMed  Google Scholar 

  • Fife TD, Blum D, Fisher RS (2006) Measuring the effects of antiepileptic medications on balance in older people. Epilepsy Res 70:103–109

    Article  CAS  PubMed  Google Scholar 

  • Filardi S, Guerreiro CA, Magna LA, Marques Neto JF (2000) Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr 58:616–620

    CAS  PubMed  Google Scholar 

  • Fitzpatrick L (2004) A Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 5(Suppl 2):S3–S15

    Article  PubMed  Google Scholar 

  • Gandelman-Marton R, Arlazoroff A, Dvir Z (2006) Balance performance in adult epilepsy patients. Seizure 15:582–589

    Article  PubMed  Google Scholar 

  • Guo CY, Ronen GM, Atkinson SA (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 42:1141–1147

    Article  CAS  PubMed  Google Scholar 

  • Hahn TJ, Birge SJ, Scharp CR, Avioli LV (1972a) Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest 51:741–748

    Article  CAS  PubMed  Google Scholar 

  • Hahn TJ, Hendin BA, Scharp CR, Haddad JG Jr (1972b) Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 287:900–904

    Article  CAS  PubMed  Google Scholar 

  • Heaney RP (2008) Vitamin D: criteria for safety and efficacy. Nutr Rev 66:S178–S181

    Article  PubMed  Google Scholar 

  • Holick MF (2005) Stay tuned to PXR: an orphan actor that may not be D-structive only to bone. J Clin Invest 115:32–34

    CAS  PubMed  Google Scholar 

  • Hosseinpour F, Ellfolk M, Norlin M, Wikvall K (2007) Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. Biochem Biophys Res Commun 357:603–607

    Article  CAS  PubMed  Google Scholar 

  • Johnell O, Nilsson BE, Walloe A, Wiklund PE (1979) Bone morphology in epileptics. Calcif Tissue Int 28:93–97

    Article  CAS  PubMed  Google Scholar 

  • Kafali G, Erselcan T, Tanzer F (1999) Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila) 38:93–98

    Article  CAS  Google Scholar 

  • Kim SH, Lee JW, Choi KG, Chung HW, Lee HW (2007) A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 10:291–295

    Article  PubMed  Google Scholar 

  • Koch HU, Kraft D, von Herrath D, Schaefer K (1972) Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 13:829–834

    Article  CAS  PubMed  Google Scholar 

  • Koppel BS, Harden CL, Nikolov BG, Labar DR (2005) An analysis of lifetime fractures in women with epilepsy. Acta Neurol Scand 111:225–228

    Article  CAS  PubMed  Google Scholar 

  • Krishnamoorthy G, Karande S, Ahire N, Mathew L, Kulkarni M (2009) Bone metabolism alteration on antiepileptic drug therapy. Indian J Pediatr 76:377–383

    Article  PubMed  Google Scholar 

  • Kruse K, Kracht U, Gopfert G (1982) Response of kidney and bone to parathyroid hormone in children receiving anticonvulsant drugs. Neuropediatrics 13:3–9

    Article  CAS  PubMed  Google Scholar 

  • Kulak CA, Borba VZ, Silvado CE, de Paola L, Seibel MJ, Bilezikian JP, Boguszewski CL (2007) Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy. Arq Bras Endocrinol Metabol 51:466–471

    PubMed  Google Scholar 

  • Kumandas S, Koklu E, Gumus H, Koklu S, Kurtoglu S, Karakukcu M, Keskin M (2006) Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J Pediatr Endocrinol Metab 19:529–534

    CAS  PubMed  Google Scholar 

  • Lado F, Spiegel R, Masur JH, Boro A, Haut SR (2008) Value of routine screening for bone demineralization in an urban population of patients with epilepsy. Epilepsy Res 78:155–160

    Article  PubMed  Google Scholar 

  • Larsen JR, Larsen LS (1989) Clinical features and management of poisoning due to phenytoin. Med Toxicol Adverse Drug Exp 4:229–245

    CAS  PubMed  Google Scholar 

  • Mehregan U, Krause KH, Prager P (1979) [The frequency of adult anticonvulsant osteomalacia in relation to duration of therapy and dosage of anticonvulsants (author’s transl)]. Arch Psychiatr Nervenkr 226:299–310

    Article  CAS  PubMed  Google Scholar 

  • Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel H (2006) Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology 67:2005–2014

    Article  CAS  PubMed  Google Scholar 

  • Mintzer S, Boppana P, Toguri J, DeSantis A (2006) Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 47:510–515

    Article  CAS  PubMed  Google Scholar 

  • Mosekilde L, Melsen F (1976) Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Acta Med Scand 199:349–355

    Article  CAS  PubMed  Google Scholar 

  • Mosekilde L et al. (1979) Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short-term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol. Acta Med Scand 205:405–409

    Article  CAS  PubMed  Google Scholar 

  • O’Hare JA, Duggan B, O’Driscoll D, Callaghan N (1980) Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand 62:282–286

    Article  PubMed  Google Scholar 

  • Pack A (2005) Effects of treatment on endocrine function in patients with epilepsy. Curr Treat Options Neurol 7:273–280

    Article  PubMed  Google Scholar 

  • Pack A (2008) Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure 17(2):181–186

    Article  PubMed  Google Scholar 

  • Pack AM, Morrell MJ (2001) Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs 15:633–642

    Article  CAS  PubMed  Google Scholar 

  • Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, Randall A, Seale C, Shane E (2005) Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 57:252–257

    Article  CAS  PubMed  Google Scholar 

  • Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E (2008) Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 70:1586–1593

    Article  CAS  PubMed  Google Scholar 

  • Patsalos PN, Perucca E (2003) Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2:347–356

    Article  CAS  PubMed  Google Scholar 

  • Pearson DA (2007) Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract 22:517–544

    Article  PubMed  Google Scholar 

  • Petty SJ, Hill KD, El Haber N, Paton L, Lawrence KM, Berkovic SF, Seibel MJ, O'Brien TJ, Wark JD (2010) Balance impairment in chronic anti-epileptic drug users: a twin and sibling study. Epilepsia 51(2):280–288

    Article  CAS  PubMed  Google Scholar 

  • Petty SJ, O’Brien TJ, Wark JD (2007) Anti-epileptic medication and bone health. Osteoporos Int 18:129–142

    Article  CAS  PubMed  Google Scholar 

  • Pluskiewicz W, Nowakowska J (1997) Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges. Ultrasound Med Biol 23:553–558

    Article  CAS  PubMed  Google Scholar 

  • Rattya J et al. (2001) Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57:440–444

    CAS  PubMed  Google Scholar 

  • Sambrook PN et al. (2004) Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J Clin Endocrinol Metab 89:1572–1576

    Article  CAS  PubMed  Google Scholar 

  • Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57:445–449

    CAS  PubMed  Google Scholar 

  • Sheth RD, Hermann BP (2008) Bone in idiopathic and symptomatic epilepsy. Epilepsy Res 78:71–76

    Article  PubMed  Google Scholar 

  • Sheth RD, Binkley N, Hermann BP (2008a) Gender differences in bone mineral density in epilepsy. Epilepsia 49:125–131

    Article  PubMed  Google Scholar 

  • Sheth RD, Binkley N, Hermann BP (2008b) Progressive bone deficit in epilepsy. Neurology 70:170–176

    Article  PubMed  Google Scholar 

  • Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC (2006) Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 66:1318–1324

    Article  CAS  PubMed  Google Scholar 

  • Tekgul H, Serdaroglu G, Huseyinov A, Gokben S (2006) Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol 21:411–414

    Article  PubMed  Google Scholar 

  • Timperlake RW, Cook SD, Thomas KA, Harding AF, Bennett JT, Haller JS, Anderson RM (1988) Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population. J Pediatr Orthop 8:467–470

    CAS  PubMed  Google Scholar 

  • Tjellesen L, Nilas L, Christiansen C (1983) Does carbamazepine cause disturbances in calcium metabolism in epileptic patients? Acta Neurol Scand 68:13–19

    Article  CAS  PubMed  Google Scholar 

  • Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, Tsukahara Y, Miura M, Mayumi M (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int 44:247–253

    Article  CAS  PubMed  Google Scholar 

  • Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58:1369–1374

    Article  CAS  PubMed  Google Scholar 

  • Vasconcelos D (1973) Compression fractures of the vertebrae during major epileptic seizures. Epilepsia 14:323–328

    Article  CAS  PubMed  Google Scholar 

  • Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 43:1488–1492

    Article  CAS  PubMed  Google Scholar 

  • Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk – a meta-analysis. Acta Neurol Scand 112:277–286

    Article  CAS  PubMed  Google Scholar 

  • Vestergaard P (2008) Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy. Curr Drug Saf 3:168–172

    Article  CAS  PubMed  Google Scholar 

  • Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of antiepileptic drugs. Epilepsia 45:1330–1337

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this entry

Cite this entry

Petty, S., Wark, J. (2010). Epilepsy and Bone Health. In: Panayiotopoulos, C.P. (eds) Atlas of Epilepsies. Springer, London. https://doi.org/10.1007/978-1-84882-128-6_229

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-128-6_229

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-127-9

  • Online ISBN: 978-1-84882-128-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics